Bruce Bloom BS, DDS, JD

Dr. Bruce Bloom is Chief Executive Officer of Cures Within Reach. His journey to this position started in February 2002, when he became the Executive Director of Goldman Philanthropic Partnerships, a 501(c)(3) private operating foundation. In 2005, when Goldman Partnerships created the public charity Partnership for Cures to carry on the Goldman mission, Dr. Bloom became President and Chief Science Officer. In October 2012, Partnership for Cures changed its name to Cures Within Reach to better reflect the focus of its mission: repurposing drugs and other treatments to drive more treatments to more patients more quickly. In 2017, Dr. Bloom became CEO of Cures Within Reach. Dr. Bloom is visionary of this public charity dedicated to improving patient quality and length of life by facilitating pilot clinical trials testing repurposed treatments designed to be immediately incorporated into clinical use, or moved to commercialization.

Dr. Bloom envisioned and developed developed CureAccelerator®, the only global online repurposing research collaboration platform designed to bring together funders, clinicians, researchers, industry and lay stakeholders to conduct clinical trials that drive more repurposed treatments to more patients more quickly. CureAccelerator was funded with a grant from the Robert Wood Johnson Foundation. Dr. Bloom has profiled by several journalists following Cures Within Reach, and has been quoted in Newsweek in June 2009 and in May 2010. He and Cures Within Reach have been featured in the Washington Post, NPR's Morning Edition, Stanford Social Innovation Review, The Scientist, PharmaTech Outlook, Pharmaceutical Patent Analyst, Chemical Engineering News, Fierce Biotech, European Pharmaceutical Review, Discover Magazine, and the Marquette Intellectual Property Review.